The ELEVATE 2 Study aimed to help researchers understand if rodatristat ethyl, an investigative oral medicine, is safe and effective when used with a patient’s usual medicines for the treatment of their PAH. This study is no longer enrolling patients.
A rare disease that causes high blood pressure in the lungs and weakness in the heart.
Clinical research studies for adults diagnosed with pulmonary arterial hypertension (PAH).